NICE Analyst Ratings
Barclays Maintains Overweight on NICE, Lowers Price Target to $286
Barclays Maintains NICE Ltd(NICE.US) With Buy Rating, Cuts Target Price to $286
NICE Analyst Ratings
Wedbush Reiterates Outperform on NICE, Maintains $250 Price Target
NICE Analyst Ratings
RBC Capital Cuts Price Target on NICE to $230 From $265, Maintains Outperform Rating
RBC Cuts Price Target on NICE to $265 From $285, Says 'CEO Transition Represents Meaningful Risk,' Keeps Outperform Rating
NICE Analyst Ratings
NICE Analyst Ratings
NICE Analyst Ratings
NICE Analyst Ratings
NICE Analyst Ratings
NICE Analyst Ratings
NICE Analyst Ratings
NICE Analyst Ratings
JMP Securities Reiterates Market Outperform on NICE, Maintains $343 Price Target
NICE Analyst Ratings
Morgan Stanley Raises Price Target on NICE to $260 From $220, Keeps Overweight Rating
RBC Capital Reiterates Outperform on NICE, Maintains $238 Price Target